What is the diagnosis and management for a 27-year-old male, 5 days post-trauma, with hypogastric pain, constipation, nonbloody mucoid stools, febrile episodes, and a 3-week history of nonproductive cough, who was previously discharged with ciprofloxacin (ciprofloxacin) after an unremarkable sonographic findings and negative urine culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Management

Primary Working Diagnosis

This patient most likely has invasive bacterial enterocolitis (infectious diarrhea with colonic involvement), with the differential including neutropenic enterocolitis, given the post-trauma immunocompromised state, febrile episodes, hypogastric pain, constipation with mucoid stools, and prolonged nonproductive cough suggesting possible systemic involvement. 1, 2

The combination of hypogastric pain, fever, mucoid stools, and constipation in a post-trauma patient raises concern for:

  • Invasive bacterial gastroenteritis (Salmonella, Shigella, Campylobacter, Yersinia, or invasive E. coli) 1
  • Neutropenic enterocolitis (typhlitis) - particularly concerning given post-trauma state and fever 2, 3
  • Clostridioides difficile infection - especially after ciprofloxacin use 1
  • Post-infectious complications or secondary bacterial infection 1

The 3-week nonproductive cough may represent:

  • Concurrent respiratory infection requiring separate evaluation 1
  • Systemic manifestation of severe infection 2
  • Unrelated chronic cough etiology 1

SOAP Format Documentation

SUBJECTIVE

Chief Complaint: Severe hypogastric pain with constipation and mucoid stools

History of Present Illness:

  • 27-year-old male, 5 days post-trauma (specify trauma details)
  • Day 4 post-trauma: Onset of febrile episodes (document maximum temperature)
  • Day 5 post-trauma: Hypogastric pain associated with constipation
  • Nonbloody mucoid stools after bisacodyl-induced defecation
  • 3-week history of nonproductive cough
  • Previous evaluation 1 week ago: Unremarkable abdominal ultrasound, negative urine culture
  • Completed course of ciprofloxacin (document dose and duration)

Review of Systems:

  • Constitutional: Fever (quantify), increased thirst 2
  • GI: Hypogastric pain (rate severity 0-10), constipation, mucoid stools (frequency, volume), no hematochezia, no melena, nausea/vomiting status, oral intake tolerance
  • Respiratory: Nonproductive cough × 3 weeks, dyspnea status
  • GU: Dysuria, urinary frequency, hematuria status
  • Document: Weight loss, night sweats, recent antibiotic use, sick contacts, travel history, food exposures

OBJECTIVE

Vital Signs: (Document: Temperature, HR, BP, RR, O2 saturation, weight)

Physical Examination:

  • General: Appearance, hydration status (skin turgor, mucous membranes, capillary refill) 4
  • Abdomen: Inspection (distension, visible peristalsis), auscultation (bowel sounds quality/frequency), palpation (hypogastric tenderness, rebound, guarding, hepatosplenomegaly, masses), percussion (tympany, shifting dullness), rectal exam (stool character, occult blood, masses, tenderness) 1, 2
  • Respiratory: Lung auscultation, work of breathing 1
  • Skin: Jaundice, rashes, petechiae 1
  • Lymph nodes: Cervical, axillary, inguinal adenopathy 2

Laboratory Data (NEEDED - see below):

  • Complete blood count with differential
  • Comprehensive metabolic panel
  • C-reactive protein
  • Stool studies (see below)
  • Blood cultures if febrile

Imaging:

  • Previous: Abdominal ultrasound (unremarkable), urine culture (negative)
  • NEEDED: CT abdomen/pelvis with IV contrast 2, 3

ASSESSMENT

  1. Suspected invasive bacterial enterocolitis - likely Salmonella, Shigella, Campylobacter, Yersinia, or invasive E. coli 1, 4
  2. Rule out neutropenic enterocolitis (typhlitis) - high-risk given post-trauma state, fever, hypogastric pain 2, 3
  3. Rule out Clostridioides difficile infection - recent ciprofloxacin exposure 1
  4. Chronic nonproductive cough - requires separate evaluation for tuberculosis, atypical pneumonia, or other pulmonary pathology 1
  5. Dehydration - suggested by increased thirst 2, 4

PLAN

Immediate Diagnostic Workup (Order STAT)

Laboratory Studies:

  • Complete blood count with differential - assess for leukopenia, neutropenia, or leukocytosis 2, 4, 3
  • Comprehensive metabolic panel - evaluate electrolytes (especially potassium), renal function, glucose 4
  • C-reactive protein - quantify systemic inflammation 4
  • Blood cultures × 2 sets if temperature >38°C 1, 2
  • Stool studies:
    • Fecal leukocytes or lactoferrin 1, 4
    • Stool culture for Salmonella, Shigella, Campylobacter, Yersinia 1, 4
    • Shiga toxin assay (E. coli O157:H7) 1, 4
    • C. difficile toxin A & B (given recent ciprofloxacin use) 1
    • Stool occult blood 4
    • Consider ova and parasites if diarrhea persists >14 days 1

Imaging:

  • CT abdomen/pelvis with IV contrast - MANDATORY to evaluate for:
    • Neutropenic enterocolitis (cecal/ascending colon wall thickening >10mm indicates 60% mortality risk) 2, 3
    • Bowel perforation, abscess, or other complications 2
    • Alternative diagnoses (appendicitis, diverticulitis, inflammatory bowel disease) 1

Respiratory Evaluation (for 3-week cough):

  • Chest X-ray - rule out pneumonia, tuberculosis, malignancy 1
  • Sputum for acid-fast bacilli × 3 if tuberculosis suspected (endemic area, risk factors) 1
  • Consider sputum culture and sensitivity 1

Empirical Treatment (Start Immediately)

Antibiotic Therapy:

If patient appears toxic, has severe abdominal pain, or imaging suggests neutropenic enterocolitis:

  • Piperacillin-tazobactam 4.5g IV every 6 hours OR
  • Meropenem 1g IV every 8 hours OR
  • Imipenem-cilastatin 500mg IV every 6 hours
  • These provide coverage for Pseudomonas, Staphylococcus aureus, E. coli, Streptococcus, and anaerobes 2, 3

If patient is stable and neutropenic enterocolitis is less likely:

  • Ciprofloxacin 500mg PO every 12 hours for 3-5 days (first-line for adults) OR
  • Azithromycin 500mg PO day 1, then 250mg daily × 4 days (if local quinolone resistance or suspected Campylobacter) 4
  • HOLD antibiotics if E. coli O157:H7 confirmed - risk of hemolytic uremic syndrome 4

Add empirical C. difficile coverage if:

  • Severe illness, toxic appearance, or high clinical suspicion
  • Oral vancomycin 125mg PO every 6 hours pending C. difficile results 1

Fluid Resuscitation:

  • Aggressive IV fluid resuscitation if signs of dehydration (increased thirst, poor skin turgor, tachycardia) 2, 4
  • Lactated Ringer's or Normal Saline 1-2L bolus, then maintenance based on ongoing losses 4
  • Oral rehydration solution if patient can tolerate PO 4

Electrolyte Replacement:

  • Potassium supplementation 40-80 mEq/day divided if hypokalemic and tolerating PO 4
  • Adjust based on laboratory values 4

Bowel Rest:

  • NPO status if severe pain, distension, or concern for neutropenic enterocolitis 2
  • Nasogastric decompression if significant distension or vomiting 2
  • Advance diet as tolerated once improving 2

Avoid:

  • Anti-diarrheal agents (loperamide, diphenoxylate) - contraindicated in invasive bacterial diarrhea and C. difficile 1
  • NSAIDs - may worsen enterocolitis 2

Monitoring and Follow-up

Daily Monitoring:

  • Vital signs every 4-6 hours 4
  • Abdominal examination twice daily 2
  • Stool frequency, character, volume 4
  • Fluid intake/output 4
  • Repeat CBC with differential in 24-48 hours 2, 4
  • Repeat electrolytes in 24-48 hours 4

Duration of Antibiotics:

  • Continue IV antibiotics until neutrophil count recovers (if neutropenic) or clinical improvement with resolution of fever and ability to tolerate oral intake 2
  • Typical duration 7-10 days, adjust based on culture results and susceptibility 2, 4
  • Modify antibiotics based on culture results and antibiotic susceptibilities 2, 4

Surgical Consultation:

  • MANDATORY if:
    • Signs of perforation (free air, peritonitis) 2
    • Abscess formation 2
    • Clinical deterioration despite aggressive medical therapy 2
    • CT shows bowel wall thickening >10mm with clinical toxicity 2

Lacking Diagnostics Summary

Critical Missing Information:

  1. Complete blood count with differential - assess for neutropenia/leukopenia (neutropenic enterocolitis risk) 2, 3
  2. Comprehensive metabolic panel - electrolytes, renal function 4
  3. Stool studies - fecal leukocytes, culture, C. difficile toxin, Shiga toxin 1, 4
  4. CT abdomen/pelvis with IV contrast - evaluate for neutropenic enterocolitis, complications 2, 3
  5. Chest X-ray - evaluate 3-week cough 1
  6. Blood cultures - if febrile 1, 2
  7. Vital signs documentation - temperature curve, hemodynamic stability 2, 4
  8. Detailed trauma history - mechanism, injuries, treatments received 3

Critical Pitfalls to Avoid

  • Do not dismiss this as simple constipation or viral gastroenteritis - the combination of post-trauma state, fever, and mucoid stools warrants aggressive evaluation for neutropenic enterocolitis 2, 3
  • Do not delay CT imaging - neutropenic enterocolitis has 50-100% mortality if not diagnosed early 2, 3
  • Do not use anti-diarrheal agents - contraindicated in invasive bacterial diarrhea 1
  • Do not withhold antibiotics pending cultures if patient appears toxic or has concerning imaging 2
  • Do not ignore the 3-week cough - tuberculosis must be ruled out, especially in endemic areas 1
  • Do not assume previous negative workup rules out serious pathology - clinical deterioration mandates repeat evaluation 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Suspected Bacterial Gastroenteritis with Concerning Laboratory Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Gastrointestinal Infection with Leukocytosis, Hidden Blood, Hypokalemia, and Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the appropriate evaluation and management approach for a patient with a chronic cough lasting greater than 1 month, considering potential underlying causes such as respiratory conditions, allergies, or infections?
What is the relationship between diarrhea, Human Immunodeficiency Virus (HIV), neutropenia, and enterocolitis?
What is the management approach for a patient presenting with neutropenia and abdominal pain?
What should I order for a patient with a new onset cough and crackle lung sounds at the base?
What is the initial approach to managing a non-productive cough in an afebrile patient?
What are the dosing considerations for calcium channel blockers in a typical adult patient with hypertension?
What is the next best step in managing a patient with a chronic cough and mild blebs on chest Computed Tomography (CT) scan, who has already been treated with antibiotics?
What are the requirements for documenting Continuous Positive Airway Pressure (CPAP) compliance for Medicare in adult patients with obstructive sleep apnea?
What is the best treatment approach for a 65-year-old patient with Hypertension (HTN) and Type 2 Diabetes Mellitus (T2DM), currently on Metformin (Metformin) and Hydrochlorothiazide (HCTZ), with uncontrolled blood pressure and Impaired renal function?
What is the best approach for rate control in a patient with atrial fibrillation (AFib) and tachycardia, with a heart rate of 106 beats per minute (bpm)?
What are the best combination of antiepileptic drugs (AEDs), such as lamotrigine and levetiracetam, for treating focal seizures in pediatric patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.